seed
Stage
2
Investors
About
LeaFix Medical develops a transcatheter mitral valve repair system that augments the anterior mitral leaflet using an implant and dedicated delivery system. The company is in animal (preclinical) trials.
Explore LeaFix Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.